For the past decade, developed-market stocks have mostly outshone emerging markets. But for Carrhae Capital, the Blackstone Group Inc.-backed hedge fund that’s handed its investors the best emerging-market equity returns among peers this year, the tide is turning.
Ali Akay, the London-based chief investment officer of Carrhae, expects returns on developing-nation equities to surpass those of the U.S. and Europe. Emerging markets didn’t fully benefit from low interest rates in the past decade and the potential for more stimulus, especially from China, should provide some support.
“We are optimistic on the trajectory of emerging markets,” Akay said in an interview. “Asset prices haven’t been juiced up as much. We just got through almost a decade of underperformance versus U.S. assets.”
While the pace of recovery in emerging economies outside of China has been weak, growth will accelerate from the second quarter of next year as central banks feel little pressure
(Bloomberg) — Emerging-market stocks can’t catch a break.
Already a laggard in the global risk rally, they have just registered their longest losing sequence of daily declines since February as the selloff in U.S. technology shares adds to headwinds that include the rising tensions between Washington and Beijing in the run-up to the U.S. presidential election.
The MSCI Emerging Markets Index fell for the sixth consecutive day on Wednesday, dipping below a key support level — its 50-day moving average — for the first time since May. Investors got spooked by AstraZeneca Plc’s decision to pause its coronavirus vaccine trial and the Trump administration’s move to bar some companies based in China’s Xinjiang region.